Results 81 to 90 of about 19,354 (307)

The International TrifectaTM and EpicTM Valve‐in‐Valve Registry: Insights Into Clinical & Hemodynamic Outcomes

Catheterization and Cardiovascular Interventions, Volume 105, Issue 7, Page 1711-1718, June 1, 2025.
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler, Mohamed Abdel‐Wahab, Nick Curzen, Manuel Wilbring, Christoph Dubois, Kayan Lam, Gloria Faerber, Jana Nagel, Holger Thiele, Michael A. Borger   +9 more
wiley   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

Case Reports in Cardiology, 2022
Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang, Hui Xue, Lifu Miao, Xiujie Tang, Yanbin Shao   +4 more
doaj   +1 more source

Isolated aortic valve replacement with the Björk-Shiley tilting disc prosthesis and the porcine bioprosthesis [PDF]

, 2017
Between 1977 and 1978, 239 patients underwent aortic valve replacement with either a bioprosthesis (100, BIO) or a Björk-Shiley tilling disc prosthesis (139, BS). Early mortality was 2%, late mortality 4%.
EGLOFF, L., ROTHLIN, M., SENNING, Å., TURINA, M.   +3 more
core  

Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up [PDF]

, 2016
Transcatheter mitral valve implantation for mitral valve regurgitation is in the very early phase of development because of challenging anatomy and device dimensions.
Cammalleri, V, De Vico, P, Marchei, M, Muscoli, S, Quadri, A, Romeo, F, Ruvolo, G, Sondergaard, L, Ussia, Gp   +8 more
core   +1 more source

European experience with the Mosaic bioprosthesis [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2002
The purpose of this study was to prospectively evaluate the clinical and hemodynamic performance of the Mosaic bioprosthesis (Medtronic, Inc, Minneapolis, Minn).The stented porcine bioprosthesis combines the amino-oleic acid antimineralization treatment and the zero-pressure differential fixation technique for improved tissue durability.
Eichinger, Walter Benno, Botzenhardt, Florian, Gunzinger, Ralf, Kemkes, Bernhard M., Sosnowski, Andrzej, Maïza, Dominique, Coto, Eduardo Otero, Bleese, Niels   +7 more
openaire   +2 more sources

Mitral Valve Bioprosthesis Is Safer Than Mechanical Mitral Prosthesis in Young Women.

Heart Surgery Forum, 2020
BACKGROUND The ultimate goal of mitral valve surgery in young women is to extend life expectancy and improve quality of life. Mitral valve replacement (MVR) prosthesis in middle-aged women is a difficult choice between the lifelong anticoagulation by ...
Hamdy Singab, Gamal Sami
semanticscholar   +1 more source

In Vitro Evaluation of Biomaterials for Heart Valve Prosthesis: High Hydrostatic and Enzymatic Treatments as Alternative for Bio‐Derived Materials

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 113, Issue 6, June 2025.
ABSTRACT Various biomaterials are currently used in clinical settings for heart valve repair and replacement. However, the optimal tissue preparation technique remains elusive. In this study, a non‐crosslinked tissue obtained from bovine pericardium, developed by Adeka Corporation, was compared with three commercially‐available tissues: two fixed ...
Danila Vella, Parnaz Boodagh, Laura Modica De Mohac, Sang‐Ho Ye, Federica Cosentino, Federica Scaglione, Sofia Dei Bardi, Giulia Polizzi, Garrett Coyan, William R. Wagner, Gaetano Burriesci, Antonio D'Amore   +11 more
wiley   +1 more source

Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation

Catheterization and Cardiovascular Interventions, Volume 105, Issue 5, Page 1161-1170, April 1, 2025.
ABSTRACT Background Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐
Juri Iwata, Kentaro Hayashida, Ryo Arita, Tomonari Moriizumi, Akiyoshi Kajino, Shingo Sakata, Toshinobu Ryuzaki, Keitaro Shinada, Hikaru Tsuruta, Yoshitake Yamada, Jungo Kato, Tatsuo Takahashi, Masataka Yamazaki, Masahiro Jinzaki, Hideyuki Shimizu, Masaki Ieda   +15 more
wiley   +1 more source

Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design [PDF]

, 2017
OBJECTIVES The aim was to investigate the safety and feasibility of the redesigned Engager™ transcatheter aortic valve implantation (TAVI) system.
Bleiziffer, Sabine, Corti, Roberto, Falk, Volkmar, Grünenfelder, Jürg, Lange, Rüdiger, Linke, Axel, Rastan, Ardawan J., Sündermann, Simon H.   +7 more
core   +1 more source

Changing trends in aortic valve procedures over the past ten years-from mechanical prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National Cardiac Surgery Database.

Journal of Thoracic Disease, 2019
Background Aortic valve replacement (AVR) is one of the most common surgeries performed in cardiac surgery operating rooms. We present actual, real life trends from the last 10 years for AVR interventions based on a multicentre National Registry of ...
K. Bartus, J. Sadowski, R. Litwinowicz, Grzegorz Filip, M. Jasinski, M. Deja, M. Kuśmierczyk, S. Pawlak, M. Jemielity, D. Jagielak, P. Hendzel, P. Suwalski, Z. Tobota, B. Maruszewski, B. Kapelak   +14 more
semanticscholar   +1 more source